Elite Pharmaceuticals Inc (ELTP)
0.3917
0.00 (0.00%)
USD |
OTCM |
Oct 04, 16:00
Elite Pharmaceuticals Shareholders Equity (Annual): 57.58M for March 31, 2024
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
March 31, 2024 | 57.58M |
March 31, 2023 | 28.96M |
March 31, 2022 | 25.22M |
March 31, 2021 | 16.15M |
March 31, 2020 | 10.66M |
March 31, 2019 | -2.508M |
March 31, 2018 | 18.48M |
March 31, 2017 | 25.66M |
March 31, 2016 | 11.16M |
March 31, 2015 | 0.2689M |
March 31, 2014 | -81.20M |
March 31, 2013 | -8.673M |
March 31, 2012 | -14.98M |
Date | Value |
---|---|
March 31, 2011 | -17.87M |
March 31, 2010 | -10.60M |
March 31, 2009 | 5.943M |
March 31, 2008 | 10.55M |
March 31, 2007 | 3.510M |
March 31, 2006 | 9.774M |
March 31, 2005 | 5.702M |
March 31, 2004 | 4.048M |
March 31, 2003 | 5.426M |
March 31, 2002 | 8.154M |
March 31, 2001 | 9.180M |
March 31, 2000 | 5.565M |
March 31, 1999 | 2.80M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
10.66M
Minimum
2020
57.58M
Maximum
2024
27.71M
Average
25.22M
Median
2022
Shareholders Equity (Annual) Benchmarks
Biomarin Pharmaceutical Inc | 4.952B |
BioCardia Inc | -1.603M |
Zevra Therapeutics Inc | 61.86M |
Verrica Pharmaceuticals Inc | 19.76M |
Terns Pharmaceuticals Inc | 255.37M |